Connection

Claus Bachert to Anti-Allergic Agents

Back to Details
This is a "connection" page, showing publications Claus Bachert has written about Anti-Allergic Agents.
Claus Bachert
Connection Strength
0.997
Anti-Allergic Agents
  1. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.653
  2. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1418-1429.
    View in: PubMed
    Score: 0.163
  3. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct; 140(4):950-958.
    View in: PubMed
    Score: 0.144
  4. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology. 2017 Jun 01; 55(2):152-160.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.